TI-520

N/A

Report date: 2025/01/26 17:20:30

Base Information

Drug NameTI-520
Drug Alias NameTreg cell therapy (Teraimmune)Treg cell therapy (Baudax Bio)TI-520
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionRegulatory T-lymphocytes modulatorsImmunostimulants
TargetsUpdating
Therapy Area/IndicationsEczemaDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTeraImmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesBaudax Bio Inc
Inactive CompaniesTeraImmune Inc
Active IndicationsEczemaDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A